Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05285007 · ClinicalTrials.gov registry record · NA

Limited Ankle Dorsiflexion and Effect on Single Limb Squats in Individuals With Patellofemoral Pain

A NA study of Patellofemoral Pain, sponsored by Loma Linda University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05285007 is a NA study of Patellofemoral Pain that is actively recruiting participants, run by Loma Linda University. The registered enrollment target is 60 participants, below the 158-participant average among 5 other Patellofemoral Pain trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05285007, a NA study of Patellofemoral Pain, is actively recruiting participants, sponsored by Loma Linda University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this graduate student research study is to investigate the relationship between limited ankle dorsiflexion and the potential effects on a single limb squat task in the Patellofemoral/Knee Pain population.

Conditions Studied

Interventions

  • OTHER Mobilization with Movement
  • OTHER No mobilization with movement and education

Study Locations (1)

California

  • Loma Linda University - Loma Linda

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2022-03-02
Est. Completion 2026-05
Phase NA

Sponsor

Loma Linda University

237 total trials

What the Registry Record Tells You About NCT05285007

The ClinicalTrials.gov registry entry for NCT05285007 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 158-participant average among 5 other Patellofemoral Pain trials with a reported enrollment target (62% lower). The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Patellofemoral Pain appearing as the primary indexed condition, and to 2 interventions - of which Mobilization with Movement is the first listed.

NCT05285007 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05285007 about?

NCT05285007 is a clinical study titled "Limited Ankle Dorsiflexion and Effect on Single Limb Squats in Individuals With Patellofemoral Pain". The purpose of this graduate student research study is to investigate the relationship between limited ankle dorsiflexion and the potential effects on a single limb squat task in the Patellofemoral/Knee Pain population.

What is the current status of trial NCT05285007?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-03-02. Estimated completion is 2026-05.

What conditions does trial NCT05285007 study?

This clinical trial studies the following conditions: Patellofemoral Pain.

What interventions are being tested in trial NCT05285007?

The interventions under investigation include: Mobilization with Movement (OTHER), No mobilization with movement and education (OTHER).

Who is sponsoring clinical trial NCT05285007?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05285007 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Patellofemoral Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.